Related references
Note: Only part of the references are listed.Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints
Noemi Andor et al.
BLOOD (2019)
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M. Ansell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Tetraspanins in infections by human cytomegalo- and papillomaviruses
Laura A. Fast et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
CD81 as a tumor target
Felipe Vences-Catalan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Tetraspanins: Spanning from solid tumors to hematologic malignancies
Ying-Gui Yang et al.
EXPERIMENTAL HEMATOLOGY (2016)
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
Niels W. C. J. van de Donk et al.
IMMUNOLOGICAL REVIEWS (2016)
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
Thomas Boyer et al.
ONCOTARGET (2016)
Tetraspanin CD81 Promotes Tumor Growth and Metastasis by Modulating the Functions of T Regulatory and Myeloid-Derived Suppressor Cells
Felipe Vences-Catalan et al.
CANCER RESEARCH (2015)
Prevention of Hepatitis C Virus Infection and Spread in Human Liver Chimeric Mice by an Anti-CD81 Monoclonal Antibody
Changhua Ji et al.
HEPATOLOGY (2015)
A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression
Felipe Vences-Catalan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab
I. S. Nijhof et al.
LEUKEMIA (2015)
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
Vashti Irani et al.
MOLECULAR IMMUNOLOGY (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Translational Medicine in Action: Anti-CD20 Therapy in Lymphoma
Sean H. Lim et al.
JOURNAL OF IMMUNOLOGY (2014)
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
K. A. Beckwith et al.
LEUKEMIA (2014)
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
B. Paiva et al.
LEUKEMIA (2012)
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
Cristina Gomez-Abad et al.
BLOOD (2011)
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Robert F. Luo et al.
HUMAN PATHOLOGY (2010)
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
Menno C. van Zelm et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
Junji Hiraga et al.
BLOOD (2009)
Vaccines for lymphomas: Idiotype vaccines and beyond
Roch Houot et al.
BLOOD REVIEWS (2009)
Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention
Claudia Stolz et al.
LEUKEMIA & LYMPHOMA (2009)
Targeting of tetraspanin proteins - potential benefits and strategies
Martin E. Hemler
NATURE REVIEWS DRUG DISCOVERY (2008)
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain
Samir Yalaoui et al.
PLOS PATHOGENS (2008)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection
F Masciopinto et al.
VIROLOGY (2002)
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
A Higginbottom et al.
JOURNAL OF VIROLOGY (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
